ContraFect Corporation
LYSIN CF-301 RESENSITIZES METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUA (MRSA) TO PENICILLIN DERIVATIVES AND FIRST GENERATION CEPHALOSPORINS

Last updated:

Abstract:

Disclosed are methods of resensitizing a Gram-positive bacterium in a subject to at least one .beta.-lactam antibiotic, comprising co-administering the Gram-positive bacterium with the at least one .beta.-lactam antibiotic and a lysin polypeptide, thereby resensitizing the Gram-positive bacterium in the subject to the at least one .beta.-lactam antibiotic.

Status:
Application
Type:

Utility

Filling date:

21 Jun 2019

Issue date:

26 Aug 2021